Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ONCO
#4533
Onconetix, Inc. Common Stock
1.940
0
USD
-39.75%
Sektör:
Sağlık hizmetleri
Baz:
USD
Kar para birimi:
USD
Günlük aralık
Yıllık aralık
Günlük değişim
-39.75%
Aylık değişim
+198.42%
6 aylık değişim
+155.26%
Yıllık değişim
+155.26%
Önceki kapanış
3.220
0
Open
1.940
0
Bid
1.940
0
Ask
1.943
0
Low
1.940
0
High
1.940
0
Hacim
8
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ONCO
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
19.52 K
104.37 K
104.37 K
309.14 K
312.13 K
716.85 K
—
Valuation ratios
Enterprise value
—
—
—
1.17 M
170.74 K
-4.1 M
—
Price to earnings ratio
—
—
—
0
0
-0.02
—
Price to sales ratio
—
—
—
0.02
0.03
0.36
—
Price to cash flow ratio
—
—
—
0
0
-0.03
—
Price to book ratio
—
—
—
0
0
0.02
—
Enterprise value to EBITDA ratio
—
—
—
-0.16
-0.09
-0.02
—
Profitability ratios
Return on assets %
-0.06
-1.04
-0.46
-0.12
-0.45
0.23
-0.8
Return on equity %
-0.09
-3.45
-2.14
-0.4
-2.6
0.36
-4.79
Return on invested capital %
-14.27
-199.01
-148.99
-28.64
-27.68
-17.58
-222.9
Gross margin %
25.91
92.7
45.1
66.2
88.55
81.58
281.44
Operating margin %
-650.32
-4 093.66
-12.37 K
-1 817.4
-681.45
-422.06
-15.29 K
EBITDA margin %
-600.16
-3 993.36
-12.28 K
-1 817.4
-643.52
-420.77
-15.16 K
Net margin %
-940.72
-4 134.74
-8 408.82
-2 227.77
-2 892.7
1 867.51
-11.66 K
Liquidity ratios
Quick ratio
0.05
0.05
0.16
0.06
0.07
0.65
0.94
Current ratio
0.06
0.05
0.17
0.07
0.08
0.66
0.99
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0
0.01
0.02
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
-0
0
0
-0
Long term debt to total equity ratio
0
0
0
-0
0
0
-0
Per share metrics
Operating cash flow per share
5 867.2
3 108
46.76
12.33
11.38
-86.8
-16.32
EBIT per share
-860.92
-4 511.64
-293.93
-17.05
-7.36
-6.83
-325.17
EBITDA per share
-794.53
-4 401.1
-291.76
-17.05
-6.95
-6.81
-322.57
Total debt per share
—
—
—
—
—
—
—
Cash per share
97.62
170.27
37.41
2.64
2.85
27.84
70.74
Net current asset value per share
340.98
147.1
56.6
8.2
4.63
32.35
101.78
Tangible book value per share
-8 578.51
-2 864.69
5 579.82
2 149.57
966.91
-14.85
8 681.45
Working capital per share
-5 306.43
-2 684.13
-271.67
-103.6
-53.37
-16.37
-445
Book value per share
11.03 K
1 322.36
5 958.83
2 309.21
1 031.59
84.06
9 383.69
Haberler
Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories - TipRanks.com
What's Going On With Onconetix Shares On Friday? - Onconetix (NASDAQ:ONCO)
Realbotix robotu Teksas’ta Ericsson 6G testinde yer aldı
Onconetix, 25 Mart’ta geçerli olacak 1’e 5 ters hisse bölünmesini onayladı
Onconetix, Inc. (ONCO) M&A Call Transcript
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.34%
Oncopeptides 2025 3. Çeyrek: Gelirler %174 artarken 2026 için kârlılık hedefi belirlendi
Oncopeptides Q3 2025 slides: Revenue surges 174% as profitability target set for 2026
Oncopeptides’in 2025 3. Çeyrek Kazanç Raporu %174’lük Satış Artışını Gösteriyor
Earnings call transcript: Oncopeptides Q3 2025 reveals 174% sales surge
Enzymatica, Holger Lembrér’i yeni CFO olarak atadı
Enzymatica appoints Holger Lembrér as new CFO